Related Experiment Video
Updated: Feb 17, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Cutaneous Fusariosis in a Pediatric Patient With Leukemia: A Diagnostic and Therapeutic Challenge
María T Berumen Murra1, Verónica Martínez García1, Guadalupe Maldonado Colín1
1Department of Dermatology, National Medical Center 20 de Noviembre Institute of Security and Social Services for State Workers (ISSSTE), Mexico City, MEX.
Abstract:
Fusariosis is a rare opportunistic fungal infection that primarily affects immunocompromised patients. Due to its nonspecific initial clinical manifestations, diagnosis is often delayed, which has a negative impact on patient outcomes. We report the case of an eight-year-old male patient with relapsed acute B-cell lymphoblastic leukemia and central nervous system involvement who developed fever and neutropenia during chemotherapy. Even though treatment with broad-spectrum antibiotic therapy was initiated, the patient developed disseminated cutaneous lesions characterized by erythematous macules that later progressed to necrotic plaques. Antifungal therapy with amphotericin B and voriconazole was established, but the patient's clinical condition deteriorated rapidly, resulting in septic shock and a fatal outcome. Histopathological examination and fungal cultures confirmed the diagnosis of invasive fusariosis. This case highlights the importance of early recognition of cutaneous manifestations of fusariosis in immunocompromised pediatric patients and emphasizes the need for multidisciplinary management to improve clinical outcomes.
Insights
Fusariosis, a rare fungal infection, can be fatal in immunocompromised children, especially those with leukemia. Early recognition of skin lesions is crucial for timely intervention and improved outcomes in pediatric fusariosis cases.
Area of Science:
- Mycology
- Infectious Diseases
- Pediatric Oncology
Background:
- Fusariosis is a rare opportunistic fungal infection.
- It primarily affects immunocompromised patients, often leading to delayed diagnosis and poor outcomes.
- Nonspecific clinical manifestations contribute to diagnostic challenges.

